CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-09 | Schlanger David J Executive Chairman | Sale 10b5-1 | −19,490 | $38.25 | $745K | 73,487 |
| 2023-05-09 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −100,000 | 516,821 | ||
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +32,000 | $3.95 | $126K | 247,924 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,348 | $36.76 | $50K | 246,576 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −24,382 | $37.61 | $917K | 222,194 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,270 | $38.24 | $240K | 215,924 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −337 | $36.76 | $12K | 77,413 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,095 | $37.61 | $229K | 65,223 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,568 | $38.24 | $60K | 63,655 |
| 2023-05-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −32,000 | 1,008,164 | ||
| 2023-05-08 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +67,887 | $0.91 | $62K | 141,374 |
| 2023-05-08 | Schlanger David J Executive Chairman | Sale 10b5-1 | −67,887 | $35.11 | $2.4M | 73,487 |
| 2023-05-08 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −67,887 | 616,821 | ||
| 2023-05-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +22,932 | $3.95 | $91K | 238,856 |
| 2023-05-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −22,932 | $35.09 | $805K | 215,924 |
| 2023-05-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,733 | $35.09 | $201K | 77,750 |
| 2023-05-08 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −22,932 | 1,040,164 | ||
| 2023-04-25 | Livingston Mark S. CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −226 | $34.52 | $8K | 63,181 |
| 2023-04-24 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +1,857 | $3.95 | $7K | 217,781 |
| 2023-04-24 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,857 | $35.00 | $65K | 215,924 |
Page 26 of 77 · 1,524 trades